Puberty in both girls and boys with type 1 diabetes has shifted forward over the last two decades, according to research presented at the 61st Annual European Society for Paediatric Endocrinology Meeting in The Hague.
New Delhi [India], August 12: In today's rapidly evolving landscape of literature, where digital platforms, audio, visuals, and print converge, a team of dedicated content researchers and editors tirelessly embark on a mission to unearth and share exceptional articles and stories. Amidst thi
Scripps Scientists have discovered that analysing a certain type of immune cell in the blood can help identify people at risk of developing type 1 diabetes, a fatal autoimmune illness. If the new approach is verified in future research, it might be used to select potential people for treatme
A research presented on Saturday at ENDO 2023, the Endocrine Society's annual conference in Chicago, Ill, said closed-loop insulin administration devices enhance glucose control in kids with type 1 diabetes without having any negative consequences.
Following promising results from pre-clinical research and a recent clinical study on stem cell-based therapies for Type 1 diabetes patients, researchers are now focusing on maximising the function and potential of stem cell-based treatments for future patient application.
A team of researchers revealed that stem cells from the human stomach may be transformed into cells that produce insulin in response to rising blood sugar levels, presenting a promising strategy for treating diabetes
A potential strategy for treating diabetes uses stem cells from the human stomach to create cells that release insulin in response to rising blood sugar levels.
Several studies have found a rise in type 1 diabetes during the COVID-19 pandemic. However, none of the research distinguishes between children infected with SARS-CoV-2 and those who are not. Researchers can now acquire fresh insights since the KVB data set contains information on whether ch
Getting a host immune system to accept the presence of implanted insulin-secreting cells could change the lives of the more than 700 million people who have Type 1 diabetes worldwide.
A little more than a century has gone since the discovery of insulin, and since then hormone's therapeutic abilities have grown and refined. Insulin is a critical treatment for type 1 diabetes and, in many cases, type 2 diabetes. According to the American Diabetes Association, 8.4 million Am
Two distinct subtypes of insulin-producing beta cells, or ss cells, have been discovered by a team of researchers led by scientists from the Van Andel Institute and Max Planck Institute of Immunobiology and Epigenetics. Each of these ss cell subtypes possesses critical traits that may be use